6- (12-Tridecene-1-yl) -2,4-Dihydroxy benzoic acid
Selected Variant
HY-161935
Size: 1 Each
6- (12-Tridecene-1-yl) -2,4-Dihydroxy benzoic acid (Compound 2) exhibits antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin enterococci (VRE) . 6- (12-Tridecene-1-yl) -2,4-Dihydroxy benzoic acid interfers with the integrity and function of the bacterial cell membrane, and affects metabolism in MRSA. 6- (12-Tridecene-1-yl) -2,4-Dihydroxy benzoic acid exhibits anti-inflammatory and anti-infective efficacy, and promotes angiogenesis in mice[1].
Product Specifications
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/6-12-tridecene-1-yl-2-4-dihydroxy-benzoic-acid.html
Smiles
OC1=C(C(O)=O)C(CCCCCCCCCCCC=C)=CC(O)=C1
Molecular Formula
C20H30O4
Molecular Weight
334.45
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD81 / TAPA-1 (C81/2885R), CF568 conjugate, 0.1mg/mL
Calgranulin B / MRP-8/-14 / MAC 387 / S100A8/A9 / Macrophage Ag (MAC387), Biotin conjugate, 0.1mg/mL
CD19 (CVID3/155), CF405S conjugate, 0.1mg/mL
Spectrin Alpha 1 (Erythrocyte Marker) (SPTA1/1832), CF740 conjugate, 0.1mg/mL
